Celcuity launches REVTORPYK for HR+/HER2- advanced breast cancerSep 30Regulatory decisionCelcuity Incgedatolisib
BioNTech Phase 3 trial of variant-adapted BNT162b2 COVID vaccine recruitingSep 30Weekly roundup, 7 itemsatirmociclibberobenatide
Tvardi's TTI-101 breast cancer trial posts results after early terminationSep 24Trial updateTTI-101Tvardi Therapeutics, Incorporated
AstraZeneca's SERENA-4 trial misses main goal for Etcamah in first-line breast cancerSep 14Clinical readoutAstraZenecacamizestrant
FDA approves AstraZeneca's Etcamah for HR-positive breast cancerSep 8Regulatory decisionAstraZenecacamizestrant
FDA drug application records confirm Etcamah approval details, dosage formSep 4Regulatory decisionAstraZenecacamizestrant
Roche results post for two terminated Morpheus umbrella trials; new Phase 1/2 studies registeredAug 7Weekly roundup, 6 itemsatezolizumabBioLineRx, Ltd.
AstraZeneca's Etcamah wins EU approval for 1st-line ER+ breast cancerJul 23Regulatory decisionAstraZenecacamizestrant
Sign inSign in